Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Lawrence Jacobs, Diane L. Cookfair, Richard A. Rudick, +23

Annals of Neurology

Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides

Niveditha Mohan, Evelyne T. Edwards, Thomas R. Cupps, +5

Arthritis & Rheumatism

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

Jack H. Simon, Lawrence Jacobs, Marilyn Campion, +32

Annals of Neurology

Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis

Jill S. Fischer, Roger L. Priore, Lawrence Jacobs, +19

Annals of Neurology

NeuropsychologyNeurological DisorderClinical NeurologyNeurological ProgressCognitive Rehabilitation +17

Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis

Jill S. Fischer, Roger L. Priore, Lawrence Jacobs, +19

Annals of Neurology

NeuropsychologyNeurological DisorderCognitive RehabilitationSocial SciencesNeurological Functioning +15

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Charlotte E. Teunissen, Til Menge, Ayşe Altıntaş, +25

Multiple Sclerosis Journal

Neuroimaging BiomarkersControl GroupsNeurological DisorderMedicineCerebrospinal Fluid +13

Adoptive Transfer of Experimental Allergic Encephalomyelitis: Incubation of Rat Spleen Cells with Specific Antigen

John R. Richert, Bernard F. Driscoll, Marian W. Kies, +1

The Journal of Immunology

Eae Spleen CellsImmunologyImmunodominanceSpecific AntigenImmunologic Mechanism +17

Open label gabapentin treatment for pain in multiple sclerosis

Maria K. Houtchens, John R. Richert, Arif Sami, +1

Multiple Sclerosis Journal

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold, +589

Neurology Clinical Practice

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1

Richard A. Rudick, Diane L. Cookfair, Nancy A. Simonian, +26

Journal of Neuroimmunology

Cerebrospinal Fluid AbnormalitiesNeurodegenerative DiseasesMultiple Sclerosis1studiesNeurobiology Of DiseaseNeurological Disorder +13